Abstract
The risk of anaphylaxis in maculopapular cutaneous mastocytosis (otherwise known as urticaria pigmentosa) is thought to be approximately 15%. Our survey of British Association of Dermatologists members elicited 40 responses: in patients with normal tryptase levels, adrenaline autoinjectors were prescribed for 10% of adults and 12% of children, increasing to 28% and 30% in those with raised tryptase. Of the 40 respondents, 95% felt a guideline would be beneficial. Thus, we propose a call for a guideline to assist clinicians with management of anaphylaxis risk in such patients, given the rarity of this condition.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
